{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:34:39Z","timestamp":1790739279790,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T00:00:00Z","timestamp":1236124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s11255-009-9541-1","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T18:21:18Z","timestamp":1236104478000},"page":"181-185","source":"Crossref","is-referenced-by-count":31,"title":["Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-\u03b1 and IL-8 production by human peripheral blood mononuclear cells"],"prefix":"10.1007","volume":"42","author":[{"given":"Theodoros","family":"Eleftheriadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Antoniadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Liakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Kartsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Stefanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grammati","family":"Galaktidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,4]]},"reference":[{"issue":"3","key":"9541_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1359\/jbmr.1998.13.3.325","volume":"13","author":"MR Haussler","year":"1998","unstructured":"Haussler MR, Whitfield GK, Haussler CA et al (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13(3):325\u2013349. doi: 10.1359\/jbmr.1998.13.3.325","journal-title":"J Bone Miner Res"},{"issue":"4","key":"9541_CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","volume":"8","author":"C Mathieu","year":"2002","unstructured":"Mathieu C, Adorini L (2002) The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 8(4):174\u2013179. doi: 10.1016\/S1471-4914(02)02294-3","journal-title":"Trends Mol Med"},{"key":"9541_CR3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/003655202753416876","volume":"37","author":"J Jahnsen","year":"2002","unstructured":"Jahnsen J, Falch JA, Mowinckel P, Aadland E (2002) Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 37:192\u2013199. doi: 10.1080\/003655202753416876","journal-title":"Scand J Gastroenterol"},{"key":"9541_CR4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","volume":"44","author":"J Nieves","year":"1994","unstructured":"Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687\u20131692","journal-title":"Neurology"},{"key":"9541_CR5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2005.05.009","volume":"5","author":"DL Kamen","year":"2006","unstructured":"Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114\u2013117. doi: 10.1016\/j.autrev.2005.05.009","journal-title":"Autoimmun Rev"},{"key":"9541_CR6","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","volume":"358","author":"E Hypponen","year":"2001","unstructured":"Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500\u20131503. doi: 10.1016\/S0140-6736(01)06580-1","journal-title":"Lancet"},{"key":"9541_CR7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s001980070052","volume":"11","author":"P Aguado","year":"2000","unstructured":"Aguado P, del Campo MT, Garces MV et al (2000) Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 11:739\u2013744. doi: 10.1007\/s001980070052","journal-title":"Osteoporos Int"},{"issue":"11","key":"9541_CR8","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/jn\/130.11.2648","volume":"130","author":"MT Cantorna","year":"2000","unstructured":"Cantorna MT, Munsick C, Bemiss C, Mahon BD (2000) Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130(11):2648\u20132652","journal-title":"J Nutr"},{"issue":"3","key":"9541_CR9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI115072","volume":"87","author":"JM Lemire","year":"1991","unstructured":"Lemire JM, Archer DC (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87(3):1103\u20131107. doi: 10.1172\/JCI115072","journal-title":"J Clin Invest"},{"issue":"2","key":"9541_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/08916939209150321","volume":"12","author":"JM Lemire","year":"1992","unstructured":"Lemire JM, Ince A, Takashima M (1992) 1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL\/l mice. Autoimmunity 12(2):143\u2013148. doi: 10.3109\/08916939209150321","journal-title":"Autoimmunity"},{"issue":"6","key":"9541_CR11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00403372","volume":"37","author":"C Mathieu","year":"1994","unstructured":"Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3. Diabetologia 37(6):552\u2013558. doi: 10.1007\/BF00403372","journal-title":"Diabetologia"},{"issue":"2","key":"9541_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2249.1998.00706.x","volume":"114","author":"P Larsson","year":"1998","unstructured":"Larsson P, Mattsson L, Klareskog L, Johnsson C (1998) A Vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 114(2):277\u2013283. doi: 10.1046\/j.1365-2249.1998.00706.x","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"9541_CR13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.1993.tb08210.x","volume":"94","author":"DD Branisteanu","year":"1993","unstructured":"Branisteanu DD, Leenaerts P, van Damme B, Bouillon R (1993) Partial prevention of active Heymann nephritis by 1-alpha,25-dihydroxyvitamin D3. Clin Exp Immunol 94(3):412\u2013417","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"9541_CR14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1523-1755.2002.00101.x","volume":"61","author":"CA Redaelli","year":"2002","unstructured":"Redaelli CA, Wagner M, Gunter-Duwe D et al (2002) 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants. Kidney Int 61(1):288\u2013296. doi: 10.1046\/j.1523-1755.2002.00101.x","journal-title":"Kidney Int"},{"issue":"5","key":"9541_CR15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/jhep.2001.28705","volume":"34","author":"CA Redaelli","year":"2001","unstructured":"Redaelli CA, Wagner M, Tien YH et al (2001) 1-alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Hepatology 34(5):926\u2013934. doi: 10.1053\/jhep.2001.28705","journal-title":"Hepatology"},{"issue":"4","key":"9541_CR16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4049\/jimmunol.167.4.1945","volume":"167","author":"S Gregori","year":"2001","unstructured":"Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167(4):1945\u20131953","journal-title":"J Immunol"},{"issue":"7","key":"9541_CR17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00007890-199810150-00002","volume":"66","author":"DA Hullett","year":"1998","unstructured":"Hullett DA, Cantorna MT, Redaelli C et al (1998) Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. Transplantation 66(7):824\u2013828. doi: 10.1097\/00007890-199810150-00002","journal-title":"Transplantation"},{"issue":"7","key":"9541_CR18","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00007890-199810150-00003","volume":"66","author":"MT Cantorna","year":"1998","unstructured":"Cantorna MT, Hullett DA, Redaelli C et al (1998) 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation 66(7):828\u2013831. doi: 10.1097\/00007890-199810150-00003","journal-title":"Transplantation"},{"issue":"1\u20132","key":"9541_CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","volume":"97","author":"E Etten van","year":"2005","unstructured":"van Etten E, Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97(1\u20132):93\u2013101. doi: 10.1016\/j.jsbmb.2005.06.002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9541_CR20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/1043-4666(92)90012-G","volume":"4","author":"K Muller","year":"1992","unstructured":"Muller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K (1992) 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4:506\u2013512. doi: 10.1016\/1043-4666(92)90012-G","journal-title":"Cytokine"},{"key":"9541_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1523-1755.2001.00467.x","volume":"59","author":"ML Cohen","year":"2001","unstructured":"Cohen ML, Douvdevani A, Chaimovitz C, Shany S (2001) Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients. Kidney Int 59:69\u201375. doi: 10.1046\/j.1523-1755.2001.00467.x","journal-title":"Kidney Int"},{"issue":"6","key":"9541_CR22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-3083.1993.tb03237.x","volume":"38","author":"H Xu","year":"1993","unstructured":"Xu H, Soruri A, Gieseler RK, Peters JH (1993) 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand J Immunol 38(6):535\u2013540. doi: 10.1111\/j.1365-3083.1993.tb03237.x","journal-title":"Scand J Immunol"},{"issue":"4","key":"9541_CR23","first-page":"315","volume":"56","author":"J Lindberg","year":"2001","unstructured":"Lindberg J, Martin KJ, Gonzalez EA, Acchiardo SR, Valdin JR, Soltanek C (2001) A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease. Clin Nephrol 56(4):315\u2013323","journal-title":"Clin Nephrol"},{"key":"9541_CR24","doi-asserted-by":"crossref","unstructured":"Llach F, Yudd M (2001) Paricalcitol in dialysis patients with calcitriol resistant secondary hyperparathyroidism. Am J Kidney Dis 38(5 Suppl 5):S45\u2013S50. doi: 10.1053\/ajkd.2001.28114","DOI":"10.1053\/ajkd.2001.28114"},{"issue":"8","key":"9541_CR25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/BF03347358","volume":"26","author":"MH Gannag\u00e9-Yared","year":"2003","unstructured":"Gannag\u00e9-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R (2003) Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 26(8):748\u2013753","journal-title":"J Endocrinol Invest"},{"key":"9541_CR26","unstructured":"Product information: ZemplarTM, paricalcitol (1998) Abbott Laboratories, North Chicago, IL"},{"key":"9541_CR27","volume-title":"Cytokine reference","author":"BB Aggarwal","year":"2000","unstructured":"Aggarwal BB, Samanta A, Feldmann M (2000) TNF\u03b1. In: Oppenheim JJ, Feldman M (eds) Cytokine reference, 2nd edn. Academic Press, New York","edition":"2"},{"issue":"3","key":"9541_CR28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/0006-291X(91)90384-J","volume":"176","author":"CG Larsen","year":"1991","unstructured":"Larsen CG, Kristensen M, Paludan K et al (1991) 1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun 176(3):1020\u20131026. doi: 10.1016\/0006-291X(91)90384-J","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"9541_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/IPH-120003399","volume":"24","author":"K Takahashi","year":"2002","unstructured":"Takahashi K, Horiuchi H, Ohta T, Komoriya K, Ohmori H, Kamimura T (2002) 1 alpha,25-dihydroxyvitamin D3 suppresses interleukin-1beta-induced interleukin-8 production in human whole blood: an involvement of erythrocytes in the inhibition. Immunopharmacol Immunotoxicol 24(1):1\u201315. doi: 10.1081\/IPH-120003399","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"9541_CR30","volume-title":"Cytokine reference","author":"H Lizasa","year":"2000","unstructured":"Lizasa H, Matsushima K (2000) IL-8. In: Oppenheim JJ, Feldman M (eds) Cytokine reference, 2nd edn. Academic Press, New York","edition":"2"},{"issue":"4","key":"9541_CR31","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s11255-007-9276-9","volume":"39","author":"GB Spasovski","year":"2007","unstructured":"Spasovski GB (2007) Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 39(4):1209\u20131216. doi: 10.1007\/s11255-007-9276-9","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"9541_CR32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11255-008-9379-y","volume":"40","author":"S Gelev","year":"2008","unstructured":"Gelev S, Spasovski G, Dzikova S et al (2008) Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice? Int Urol Nephrol 40(3):763\u2013770. doi: 10.1007\/s11255-008-9379-y","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"9541_CR33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","volume":"52","author":"P Alborzi","year":"2008","unstructured":"Alborzi P, Patel NA, Peterson C et al (2008) Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 52(2):249\u2013255. doi: 10.1161\/HYPERTENSIONAHA.108.113159","journal-title":"Hypertension"},{"issue":"9","key":"9541_CR34","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2007060666","volume":"19","author":"X Tan","year":"2008","unstructured":"Tan X, Wen X, Liu Y (2008) Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol 19(9):1741\u20131752. doi: 10.1681\/ASN.2007060666","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"9541_CR35","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","volume":"55","author":"J Zimmermann","year":"1999","unstructured":"Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55(2):648\u2013658. doi: 10.1046\/j.1523-1755.1999.00273.x","journal-title":"Kidney Int"},{"issue":"5","key":"9541_CR36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1525-139X.2007.00283.x","volume":"20","author":"T Eleftheriadis","year":"2007","unstructured":"Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I (2007) Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20(5):440\u2013451. doi: 10.1111\/j.1525-139X.2007.00283.x","journal-title":"Semin Dial"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9541-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-009-9541-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-009-9541-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:55:28Z","timestamp":1559390128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-009-9541-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,4]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["9541"],"URL":"https:\/\/doi.org\/10.1007\/s11255-009-9541-1","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,4]]}}}